(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ASTEX

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ASTEX

ST13

US500000085979354

Classe

9, 42, 44

Pedido

85979354

Registro

4373776

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

56

Atualização mais recente

26/11/2024

Tipo de marca

Verbal

Classes Nice

9, 42, 44

Data de depósito

13/10/2011

Data de registro

23/07/2013

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

29/02/2024

Última transação

26/11/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

13/03/2012

Primeiro uso no comércio

27/03/2012

Código do desenho

4

Tipo de titular

24

Localização do titular

CAMBRIDGE, GB

Examinador

KEAN, AMY

Unidade examinadora

M40

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

ASTEX THERAPEUTICS LIMITED
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.

Representantes

Carole E. Klinger Fross Zelnick Lehrman & Zissu, P.C.

Classificação técnica

Classes Nice

Classe 9Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Computer software for the manipulation and presentation of data for use in relation to drug discoverybiotechnology research and scientific analysis

Classe 42

Research and development services in the field of pharmaceuticals; providing medical and scientific health care research information in the field of pharmaceuticals and clinical trials; drug discovery services; biotechnology research; scientific research and analysis in the field of drug discovery and pharmaceutical drug development

Classe 44

Providing health care information via the Internet; providing information in the field of diagnosticprophylactictherapeutic properties of pharmaceuticals

Publicações

Histórico de despachos e eventos da marca no USPTO.

56 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

22/11/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

22/11/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

22/11/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

22/11/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/08/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/08/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/08/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

15/08/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

15/08/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

29/02/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

29/02/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

29/02/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

29/02/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/01/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

07/09/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

23/07/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/04/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/04/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/04/2022

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/09/2019

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/09/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/09/2019

E815

TEAS SECTION 8 & 15 RECEIVED

23/07/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

23/07/2018

CORV

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

05/04/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/01/2017

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/03/2015

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/03/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

23/07/2013

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

20/06/2013

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

19/06/2013

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

17/06/2013

SUPC

STATEMENT OF USE PROCESSING COMPLETE

29/05/2013

DPCC

DIVISIONAL PROCESSING COMPLETE

29/05/2013

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

21/05/2013

IUAF

USE AMENDMENT FILED

17/05/2013

DRRR

DIVISIONAL REQUEST RECEIVED

17/05/2013

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

17/05/2013

EISU

TEAS STATEMENT OF USE RECEIVED

17/05/2013

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

20/11/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/09/2012

PUBO

PUBLISHED FOR OPPOSITION

25/09/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/09/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

22/08/2012

ALIE

ASSIGNED TO LIE

22/08/2012

ALIE

ASSIGNED TO LIE

17/08/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/08/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/08/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/08/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/08/2012

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

07/02/2012

GPRA

PRIORITY ACTION E-MAILED

07/02/2012

CPRA

PRIORITY ACTION WRITTEN

07/02/2012

DOCK

ASSIGNED TO EXAMINER

01/02/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

18/10/2011

NWAP

NEW APPLICATION ENTERED

17/10/2011

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ASTEX ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.